scholarly journals The Cellular and Physiological Functions of the Lowe Syndrome Protein OCRL1

Traffic ◽  
2014 ◽  
Vol 15 (5) ◽  
pp. 471-487 ◽  
Author(s):  
Zenobia B. Mehta ◽  
Grzegorz Pietka ◽  
Martin Lowe

2007 ◽  
Vol 13 (3) ◽  
pp. 377-390 ◽  
Author(s):  
Kai S. Erdmann ◽  
Yuxin Mao ◽  
Heather J. McCrea ◽  
Roberto Zoncu ◽  
Sangyoon Lee ◽  
...  


Traffic ◽  
2005 ◽  
Vol 6 (9) ◽  
pp. 711-719 ◽  
Author(s):  
Martin Lowe


PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e24044 ◽  
Author(s):  
Adam G. Grieve ◽  
Rachel D. Daniels ◽  
Elena Sanchez-Heras ◽  
Matthew J. Hayes ◽  
Stephen E. Moss ◽  
...  


Cilia ◽  
2012 ◽  
Vol 1 (S1) ◽  
Author(s):  
V Hernandez ◽  
BG Coon ◽  
K Madhivanan ◽  
D Mukherjee ◽  
CB Hanna ◽  
...  


2012 ◽  
Vol 21 (8) ◽  
pp. 1835-1847 ◽  
Author(s):  
Brian G. Coon ◽  
Victor Hernandez ◽  
Kayalvizhi Madhivanan ◽  
Debarati Mukherjee ◽  
Claudia B. Hanna ◽  
...  


2006 ◽  
Vol 25 (16) ◽  
pp. 3750-3761 ◽  
Author(s):  
Noora Hyvola ◽  
Aipo Diao ◽  
Eddie McKenzie ◽  
Alison Skippen ◽  
Shamshad Cockcroft ◽  
...  


PLoS Genetics ◽  
2015 ◽  
Vol 11 (4) ◽  
pp. e1005058 ◽  
Author(s):  
Francesca Oltrabella ◽  
Grzegorz Pietka ◽  
Irene Barinaga-Rementeria Ramirez ◽  
Aleksandr Mironov ◽  
Toby Starborg ◽  
...  


2015 ◽  
Vol 396 (12) ◽  
pp. 1293-1300 ◽  
Author(s):  
Shruti Sharma ◽  
Agnieszka Skowronek ◽  
Kai Sven Erdmann

Abstract Mutations of the inositol-5-phosphatase OCRL cause Lowe syndrome and Dent-II disease. Both are rare genetic disorders characterized by renal defects. Lowe syndrome is furthermore characterized by defects of the eye (congenital cataracts) and nervous system (mental disabilities, hypotonia). OCRL has been localised to various endocytic compartments suggesting impairments in the endocytic pathway as possible disease mechanism. Recent evidence strongly supports this view and shows essential roles of OCRL at clathrin coated pits, transport of cargo from endosomes to the trans-Golgi network as well as recycling of receptors from endosomes to the plasma membrane. In particular in vitro and in vivo evidence demonstrates an important role of OCRL in recycling of megalin, a multi-ligand receptor crucial for reabsorption of nutrients in the proximal tubulus, a process severely impaired in Lowe syndrome patients. Thus defects in the endocytic pathway are likely to significantly contribute to the kidney phenotype in Lowe syndrome and Dent-II disease.





2005 ◽  
Vol 16 (8) ◽  
pp. 3467-3479 ◽  
Author(s):  
Rawshan Choudhury ◽  
Aipo Diao ◽  
Fang Zhang ◽  
Evan Eisenberg ◽  
Agnes Saint-Pol ◽  
...  

Oculocerebrorenal syndrome of Lowe is caused by mutation of OCRL1, a phosphatidylinositol 4,5-bisphosphate 5-phosphatase localized at the Golgi apparatus. The cellular role of OCRL1 is unknown, and consequently the mechanism by which loss of OCRL1 function leads to disease is ill defined. Here, we show that OCRL1 is associated with clathrin-coated transport intermediates operating between the trans-Golgi network (TGN) and endosomes. OCRL1 interacts directly with clathrin heavy chain and promotes clathrin assembly in vitro. Interaction with clathrin is not, however, required for membrane association of OCRL1. Overexpression of OCRL1 results in redistribution of clathrin and the cation-independent mannose 6-phosphate receptor (CI-MPR) to enlarged endosomal structures that are defective in retrograde trafficking to the TGN. Depletion of cellular OCRL1 also causes partial redistribution of a CI-MPR reporter to early endosomes. These findings suggest a role for OCRL1 in clathrin-mediated trafficking of proteins from endosomes to the TGN and that defects in this pathway might contribute to the Lowe syndrome phenotype.



Sign in / Sign up

Export Citation Format

Share Document